(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine

Catalog No. :
ACTVZK952
CAS No. :
138500-88-6
Molecular Formula :
C13H20BNO2
Molecular Weight :
233.12

IUPAC Name:(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine

(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$94.00Login to see priceIn stockInquiry
25g95%$444.00Login to see priceIn stockInquiry
100g95%$1555.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
IUPAC Name(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
MDL No.MFCD06213229
Molecular FormulaC13H20BNO2
Molecular Weight233.12
SMILESNCC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1
InChI KeyFPUVAGQUKWMDKN-UHFFFAOYSA-N
Synonym4-Aminomethylphenylboronic acid pinacol ester | AKOS015999093 | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-benzylamine | CS-0130396 | FT-0643288 | [4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine | Benzenemethanamine, 4-(4,4,5,5-tet
CAS No.138500-88-6
PubChem CID2773208

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTVZK952 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLMSZ156 route compound structure diagram
    ACLMSZ156171364-82-2 In Stock
  2. Then
  3. ACTVZK952 route product structure diagram
    ACTVZK952138500-88-6 In Stock
Inquiry

2. ACTVZK952 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTVH841 route compound structure diagram
    ACDTVH841330794-35-9 In Stock
  2. Then
  3. ACTVZK952 route product structure diagram
    ACTVZK952138500-88-6 In Stock
Inquiry

Comments (0)